Spots Global Cancer Trial Database for alcanza
Every month we try and update this database with for alcanza cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) | NCT01578499 | Primary Cutaneo... Mycosis Fungoid... Cutaneous T-Cel... | Brentuximab Ved... Methotrexate Bexarotene | 18 Years - | Takeda | |
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) | NCT01578499 | Primary Cutaneo... Mycosis Fungoid... Cutaneous T-Cel... | Brentuximab Ved... Methotrexate Bexarotene | 18 Years - | Takeda |